CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

This study tests whether adding a targeted form of cognitive behavioral therapy (CBT) to children's existing OCD medication can help them safely reduce or stop taking their medication — offering a path to long-term management without lifelong drug use. **You may be eligible if...** - Your child is between 7 and 17 years old - Your child has a confirmed OCD diagnosis of more than 6 months, with significant symptoms (CY-BOCS score ≥ 16) - Your child has been on a stable, maximum tolerated dose of an SRI medication (like fluoxetine, fluvoxamine, sertraline, citalopram, or escitalopram) for at least 12 weeks and still has persistent symptoms - Both the child and the participating parent are willing to attend study sessions **You may NOT be eligible if...** - Your child is taking paroxetine (due to safety concerns) - Your child has not been on a stable SRI dose for at least 12 weeks - Your child is under 7 or over 17 years old Talk to your doctor to see if this trial is right for you.